2016 —
The idea comes
The idea to conjugate passion for biotechnologies and 3d printing, is born when we were at the University. We first met there, at the university of Urbino where we use to attend the same classes. With our friendship and exchange of ideas, degree thesis and stages, begins to take shape that dream we call Prometheus.
2018—
Company
Our team is consolidated, Prometheus gets bigger every day. Thanks to Democenter-Sipe foundation, TPM Cube (incubator of Mirandola) becames our headquarter Thanks to our skills, we realized our first product, Ematik, taking part to international pitchs, this opens us up to an even bigger sales market. We are a team, we are friends, we are a family.
Call for proposals to support the creation and consolidation of innovative start-ups 2018
D.G.R. 812/2018 - Asse 1 - Azione 1.4.1 POR-FESR 2014 - 2020
Prometheus is an innovative start-up company offering Ematik, an innovative patented system consisting of a machine and a disposable kit for the creation of an autologous and customised medicament for veterinary use, particularly for the treatment of difficult-to-heal skin wounds. In less than 50 minutes, the Ematik system allows the veterinarian to add the mixture of biopolymers provided in the disposable kit to the patient's blood.
Ematik can be used on animals of all sizes to accelerate and improve the healing of skin wounds. The technological innovation, demonstrated by the results of several clinical studies conducted on animals with chronic wounds, is that Ematik :
- Healing times halved compared to competing products;
- Personalised autologous medicament (obtained from the patient's own blood) and free of side effects;
- Allows the reappearance of the animal's original hair without scarring (important aspect in high value animals).
valuable animals);
- Antibacterial properties: reduces the risk of infection in the wounded area and reduces the use of antibiotics;
- Easy to apply and bioabsorbable by the wound;
- Fully automated and fast: By loading the patient's blood into the machine, Ematik enables the automated production of an autologous, personalised medicament in just 50 minutes.
By participating in the 2018 Start up call, Prometheus aimed to optimise IoT solutions and accelerate market penetration through the acquisition of:
- Machinery and technical production equipment for the production process, furniture and hardware
- Rental and hire of scientific and laboratory equipment
- Promotional expenses for the website, promotional material, advertising, scientific publications, participation in trade fairs
- Technical consultancy for product and equipment optimisation
- Strategic advice and IP protection
the following - Enhancement of the company's computer equipment through the purchase of new hardware
- strengthening of the technical-productive equipment through the purchase of specific equipment and instruments specific equipment and instruments
- supporting investments in marketing, in particular for promotional material, participation in fairs (SCIVAC) implementation of a marketing campaign and optimisation of the website
- acquisition of specialist technical advice, in particular for the optimisation of technical and production equipment, for the optimisation of hardware and software, etc. hardware/software and aesthetic/functional optimisation of the Ematik machine and its industrialisation
. industrialisation
- acquisition of specialist advice for the implementation of the sales network and for the protection of intellectual property intellectual property protection through the filing and extension of patents abroad.
